Medication Conversion Guidelines

Introduction to Labetalol and Metoprolol

The American College of Cardiology recommends that a dose of 200 mg of labetalol twice daily is approximately equivalent to 75 mg of metoprolol tartrate twice daily, considering their different pharmacological profiles 1
Labetalol is a combined alpha- and beta-receptor blocker with a recommended dose range of 200-800 mg twice daily, according to the ACC/AHA guidelines 1
Metoprolol tartrate is a selective beta-1 blocker with a recommended dose range of 100-200 mg twice daily for cardiovascular conditions, as per the ACC/AHA guidelines 1
Metoprolol is a selective beta-1 blocker without alpha-blocking effects, which is an important consideration for patient treatment 2

The target dose for metoprolol tartrate is 100-200 mg twice daily, as recommended by the American College of Cardiology 3
The target dose for labetalol is 200-800 mg twice daily, according to the ACC/AHA guidelines 1
When converting from metoprolol tartrate 75 mg BID to labetalol, an initial labetalol dose of 200 mg twice daily is recommended, with monitoring of blood pressure and heart rate response, and titration by 100 mg twice daily every 2-3 days as needed, with a maximum dose of 600 mg twice daily 1
For converting from labetalol to metoprolol tartrate, approximately 75 mg of metoprolol tartrate is used for every 200 mg of labetalol, starting at the lower end of the equivalent dose range and titrating based on blood pressure and heart rate response 1

The ratio of potency for beta-blockade appears to be approximately 2.5-3:1 (labetalol:metoprolol), which is essential for clinical comparison studies 1
Labetalol causes less reduction in heart rate than metoprolol at equivalent antihypertensive doses due to its alpha-blocking properties, which should be considered when converting between medications 1